Efficiency evaluation of selected Indian pharmaceutical firms since inception of product patent Online publication date: Mon, 04-Jan-2021
by Sucharita Bhattacharyya; Susmita Chatterjee
International Journal of Management Concepts and Philosophy (IJMCP), Vol. 13, No. 4, 2020
Abstract: The purpose is to measure the financial efficiency of selected Indian pharmaceutical firms in the product patent regime. The data envelopment analysis (DEA) technique for assessing the financial efficiency of pharmaceutical firms is used to fulfil the objectives of the study. DEA allows multiple inputs-outputs and we have applied an output-oriented the BCC model of the DEA technique which has allowed a breakdown of efficiency into technical and scale efficiency. In order to apply the DEA technique, secondary data has been collected from 63 large as well as medium/small Indian pharmaceutical companies. The results of statistical analysis are significant and reflect that the technical efficiency of the large pharmaceutical companies is higher than that of medium/small firms. Whereas the scale efficiency of medium/small companies is more than that of large companies. As medium/small firms have better scale efficiency the large firms should initiate control over their scale (size) of operation.
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Management Concepts and Philosophy (IJMCP):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email subs@inderscience.com
Our Blog 
Follow us on Twitter 
Visit us on Facebook